Today, the CEO & President of CHF Solutions Inc (NASDAQ: CHFS), John Erb, bought shares of CHFS for $50K.
Following this transaction John Erb’s holding in the company was increased by 408.66% to a total of $50.78K.
See today’s analyst top recommended stocks >>
Based on CHF Solutions Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.04 million and GAAP net loss of $4.35 million. In comparison, last year the company earned revenue of $864K and had a GAAP net loss of $2.46 million. Currently, CHF Solutions Inc has an average volume of 62.52K.
Seven different firms, including Canaccord Genuity and Cowen & Co., currently also have a Buy rating on the stock.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CHF Solutions, Inc. is a medical device company, which engages in the provision of products for the treatment of fluid overload specifically for cardiac and coronary diseases. It engages in the development, manufacture, and commercialization of Aquadex FlexFlow System, which provides an ultrafiltration treatment for patients with failed diuretic therapy and require hospitalization. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
